drugset / Trial / NCT03920215
Evaluation of the Long Term Follow up of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of this safety long-term follow-up study was to evaluate the safety of OC-01 Nasal Spray at 6 months and 12 months post treatment in the OPP-002 study (NCT03636061).
Timeline
- Start
- 2018-08-15
- Primary completion
- 2019-09-20
- Completion
- 2019-09-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Varenicline | Small molecule | 0.12 mg/ml | Intranasal |
| Comparator | Varenicline | Small molecule | 0.6 mg/ml | Intranasal |
| Comparator | Varenicline | Small molecule | 1.2 mg/ml | Intranasal |